20.61 USD
+0.28 (+1.38%)
20.75 USD
+0.14 (+0.68%)
ChartMill assigns a Buy % Consensus number of 82% to TBPH. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 27.25. This target is 32.21% above the current price.
- TBPH was analyzed by 13 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about TBPH.
- In the previous month the buy percentage consensus was at a similar level.
- TBPH was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-03 | Oppenheimer | Initiate | Outperform |
| 2025-11-26 | BTIG | Maintains | Buy -> Buy |
| 2025-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-12 | B. Riley Securities | Initiate | Buy |
| 2025-06-27 | BTIG | Maintains | Buy -> Buy |
| 2025-06-17 | Jones Trading | Initiate | Buy |
| 2025-02-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-06 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-08-06 | TD Cowen | Maintains | Hold -> Hold |
| 2024-08-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-12 | BTIG | Initiate | Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-09 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-17 | SVB Leerink | Maintains | Outperform |
| 2022-11-08 | HC Wainwright & Co. | Maintains | Buy |
| 2022-07-25 | Morgan Stanley | Maintains | Underweight |
| 2022-05-23 | SVB Leerink | Initiate | Outperform |
| 2022-03-02 | Morgan Stanley | Maintains | Underweight |
| 2022-02-24 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-05 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2021-09-16 | SVB Leerink | Maintains | Outperform |
| 2021-09-16 | Morgan Stanley | Maintains | Underweight |
| 2021-09-16 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-25 | Morgan Stanley | Downgrade | Overweight -> Underweight |
| 2021-08-24 | Needham | Maintains | Buy |
THERAVANCE BIOPHARMA INC / TBPH FAQ
Can you provide the average price target for THERAVANCE BIOPHARMA INC stock?
13 analysts have analysed TBPH and the average price target is 27.25 USD. This implies a price increase of 32.21% is expected in the next year compared to the current price of 20.61.
What is the consensus rating for TBPH stock?
The consensus rating for THERAVANCE BIOPHARMA INC (TBPH) is 81.5385 / 100 . This indicates that analysts generally have a positive outlook on the stock.